Information Journal Paper
APA:
CopyDINNISSEN, M., DIETRICH, A., & HOEKSTRA, P.J.. (2015). CLINICAL AND PHARMACOKINETIC EVALUATION OF RISPERIDONE FOR THE MANAGEMENT OF AUTISM SPECTRUM DISORDER. EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY, 11(1), 111-124. SID. https://sid.ir/paper/704693/en
Vancouver:
CopyDINNISSEN M., DIETRICH A., HOEKSTRA P.J.. CLINICAL AND PHARMACOKINETIC EVALUATION OF RISPERIDONE FOR THE MANAGEMENT OF AUTISM SPECTRUM DISORDER. EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY[Internet]. 2015;11(1):111-124. Available from: https://sid.ir/paper/704693/en
IEEE:
CopyM. DINNISSEN, A. DIETRICH, and P.J. HOEKSTRA, “CLINICAL AND PHARMACOKINETIC EVALUATION OF RISPERIDONE FOR THE MANAGEMENT OF AUTISM SPECTRUM DISORDER,” EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY, vol. 11, no. 1, pp. 111–124, 2015, [Online]. Available: https://sid.ir/paper/704693/en